197 related articles for article (PubMed ID: 35071824)
1. RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2.
Saadat KASM
Gene Rep; 2022 Mar; 26():101512. PubMed ID: 35071824
[TBL] [Abstract][Full Text] [Related]
2. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
[TBL] [Abstract][Full Text] [Related]
3. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
4. Antiviral Drug Discovery for the Treatment of COVID-19 Infections.
Ng TI; Correia I; Seagal J; DeGoey DA; Schrimpf MR; Hardee DJ; Noey EL; Kati WM
Viruses; 2022 May; 14(5):. PubMed ID: 35632703
[TBL] [Abstract][Full Text] [Related]
5. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
Hasan M; Ashik AI; Chowdhury MB; Tasnim AT; Nishat ZS; Hossain T; Ahmed S
Inform Med Unlocked; 2021; 24():100569. PubMed ID: 33846694
[TBL] [Abstract][Full Text] [Related]
6. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
Mishra D; Suri GS; Kaur G; Tiwari M
J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
[TBL] [Abstract][Full Text] [Related]
7. siRNA as a Potential Therapy for COVID-19.
Aljaberi A; Migdadi EM; Khadra KMA; Samak MA; Basheti IA; Al-Zoubi N
Curr Drug Deliv; 2022; 19(7):731-744. PubMed ID: 34353261
[TBL] [Abstract][Full Text] [Related]
8. Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains.
Madanagopal P; Muthukumar H; Thiruvengadam K
Comput Biol Chem; 2022 Jun; 98():107687. PubMed ID: 35537364
[TBL] [Abstract][Full Text] [Related]
9. Minireview of progress in the structural study of SARS-CoV-2 proteins.
Zhu G; Zhu C; Zhu Y; Sun F
Curr Res Microb Sci; 2020 Sep; 1():53-61. PubMed ID: 33236001
[TBL] [Abstract][Full Text] [Related]
10. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
[TBL] [Abstract][Full Text] [Related]
11. Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2.
Ayyagari VS
J Genet Eng Biotechnol; 2022 Apr; 20(1):65. PubMed ID: 35482116
[TBL] [Abstract][Full Text] [Related]
12. An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes.
Nawaz R; Arif MA; Ahmad Z; Ahad A; Shahid M; Hassan Z; Husnain A; Aslam A; Raza MS; Mehmood U; Idrees M
BMC Infect Dis; 2023 Dec; 23(1):872. PubMed ID: 38087193
[TBL] [Abstract][Full Text] [Related]
13. Bioactive natural compounds against human coronaviruses: a review and perspective.
Xian Y; Zhang J; Bian Z; Zhou H; Zhang Z; Lin Z; Xu H
Acta Pharm Sin B; 2020 Jul; 10(7):1163-1174. PubMed ID: 32834947
[TBL] [Abstract][Full Text] [Related]
14. Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.
Friedrich M; Pfeifer G; Binder S; Aigner A; Vollmer Barbosa P; Makert GR; Fertey J; Ulbert S; Bodem J; König EM; Geiger N; Schambach A; Schilling E; Buschmann T; Hauschildt S; Koehl U; Sewald K
Front Bioeng Biotechnol; 2022; 10():801870. PubMed ID: 35309990
[TBL] [Abstract][Full Text] [Related]
15. The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.
Kim S; Lee JH; Lee S; Shim S; Nguyen TT; Hwang J; Kim H; Choi YO; Hong J; Bae S; Jhun H; Yum H; Lee Y; Chan ED; Yu L; Azam T; Kim YD; Yeom SC; Yoo KH; Kang LW; Shin KC; Kim S
Immune Netw; 2020 Oct; 20(5):e41. PubMed ID: 33163249
[TBL] [Abstract][Full Text] [Related]
16. Roles of existing drug and drug targets for COVID-19 management.
Ayele AG; Enyew EF; Kifle ZD
Metabol Open; 2021 Sep; 11():100103. PubMed ID: 34222852
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
[TBL] [Abstract][Full Text] [Related]
18. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
Dong S; Sun J; Mao Z; Wang L; Lu YL; Li J
J Med Virol; 2020 Sep; 92(9):1542-1548. PubMed ID: 32181901
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
20.
Gurung AB
Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
